Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Veterinary medicine
Name of medicinal product: Fortekor plus
Active substances:
Estonian, English, Latin
ATC code: QC09BX90
Dosage form: tablet
Strength: 10mg+5mg
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Indication: For the treatment of congestive heart failure due to atrioventricular valve insufficiency or dilated cardiomyopathy in dogs. FORTEKOR PLUS is a fixed dose combination and should only be used in patients whose clinical signs are successfully controlled by administration of the same doses of the individual components (pimobendan and benazepril hydrochloride) given concurrently.
Safety features: No
Marketing authorization holder: Elanco GmbH 
Marketing authorization number: EU/2/15/185 
Marketing authorization issued on: September 8, 2015 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Centralised 
Assessment report:   
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported Additional information
1697294  Fortekor plus  tablet  10mg +5mg 30TK  Prescription      27.01.2020   
1697306  Fortekor plus  tablet  10mg +5mg 60TK  Prescription         
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere